首页> 外文期刊>Clinical and experimental pharmacology & physiology >Stobadine protects rat kidney against ischaemia/reperfusion injury.
【24h】

Stobadine protects rat kidney against ischaemia/reperfusion injury.

机译:斯托巴汀保护大鼠肾脏免受缺血/再灌注损伤。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

1. Ischaemia-reperfusion (I/R) injury, one of the main causes of acute renal failure, still needs satisfactory treatment for routine clinical application. Stobadine, a novel synthetic pyridoindole anti-oxidant, has the ability to reduce tissue injury induced by mechanisms involving reactive oxygen species during I/R. The aim of the present study was to determine the effects of stobadine on renal I/R injury. 2. Forty male Wistar rats were randomly divided into four groups as follows: sham, I/R, stobadine treated and I/R + stobadine treated. Stobadine (2 mg/kg, i.v.) was given intravenously to two groups of rats. The stobadine-treated group was treated with stobadine following sham operation before the abdominal wall was closed, whereas the I/R + stobadine group received stobadine at the beginning of reperfusion. Renal I/R was achieved by occluding the renal arteries bilaterally for 40 min, followed by 6 h reperfusion. Immediately thereafter, blood was drawn and tissue samples were harvested to assess: (i) serum levels of blood urea nitrogen and creatinine; (ii) serum and/or tissue levels of malondialdehyde (MDA), glutathione (GSH), glucose 6-phosphate dehydrogenase (G-6PD), 6-phosphogluconate dehydrogenase (6-PGD), glutathione reductase (GR) and glutathione peroxidase (GPx); (iii) renal morphology; and (iv) immunohistochemical staining for P-selectin. 3. Stobadine was able to significantly attenuate the renal dysfunction as a result of renal I/R injury. Ischaemia-reperfusion resulted in a significant increase in serum and kidney MDA levels and a decrease in serum and kidney GSH. Stobadine treatment at the beginning of reperfusion attenuated both the increased MDA levels and decreased GSH secondary to I/R injury. In addition, the decreased G-6PD activity observed after I/R was significantly attenuated by stobadine treatment. Stobadine did not alter 6-PGD activity after I/R. Neither GR nor GPx activity was significantly changed in the I/R alone or the I/R + stobadine groups compared with the sham group. In addition, stobadine decreased the morphological deterioration and high P-selectin immunoreactivity secondary to renal I/R injury. 4. A pyridoindole anti-oxidant, stobadine exerts a renal protective effect in renal I/R injury, which is probably due to its radical-scavenging and anti-oxidant activities.
机译:1.缺血再灌注(I / R)损伤是急性肾衰竭的主要原因之一,对于常规临床应用仍需要令人满意的治疗。 Stobadine是一种新型的合成吡啶并吲哚抗氧化剂,具有减轻I / R期间涉及活性氧的机制引起的组织损伤的能力。本研究的目的是确定司他巴定对肾脏I / R损伤的影响。 2.将四十只雄性Wistar大鼠随机分为四组:假手术,I / R,司他巴定治疗和I / R +司他巴定治疗。将斯托巴汀(2 mg / kg,静脉内)给予两组大鼠。司他巴定治疗组在假手术后于腹壁闭合之前接受司他巴定治疗,而I / R +司他巴定组在再灌注开始时接受司他巴定治疗。肾脏I / R是通过双侧阻塞肾动脉40分钟,然后再灌注6 h来实现的。此后立即抽血并收集组织样品以评估:(i)血清尿素氮和肌酐水平; (ii)血清和/或组织中的丙二醛(MDA),谷胱甘肽(GSH),葡萄糖6-磷酸脱氢酶(G-6PD),6-磷酸葡萄糖酸酯脱氢酶(6-PGD),谷胱甘肽还原酶(GR)和谷胱甘肽过氧化物酶( GPx); (iii)肾脏形态; (iv)P-选择蛋白的免疫组织化学染色。 3. Stobadine能够显着减轻肾I / R损伤导致的肾功能不全。缺血再灌注导致血清和肾脏MDA水平显着增加,血清和肾脏GSH降低。再灌注开始时的斯托巴汀治疗可减轻I / R损伤继发的MDA水平升高和GSH降低。另外,在I / R后观察到的G-6PD活性降低通过司他巴定治疗显着减弱。 I / R后,Stobadine不会改变6-PGD活性。与假手术组相比,单独I / R或I / R + stobadine组的GR和GPx活性均无明显变化。此外,司他巴定降低了继发于肾脏I / R损伤的形态学恶化和高P-选择蛋白免疫反应性。 4.吡啶吲哚抗氧化剂斯托巴汀在肾脏I / R损伤中发挥肾脏保护作用,这可能是由于其自由基清除和抗氧化剂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号